Oral Factor Xa Inhibitors versus Warfarin for the Treatment of Venous Thromboembolism in Advanced Chronic Kidney Disease

Oral Factor Xa Inhibitors versus Warfarin for the Treatment of Venous Thromboembolism in Advanced Chronic Kidney Disease

Introduction. Warfarin remains the preferred oral anticoagulant for the treatment of venous thromboembolism (VTE) in patients with advanced chronic kidney disease (CKD). Although the direct oral anticoagulants (DOACs) have become preferred for treatment of VTE in the general population, patients wit...

Full description

Bibliographic Details
Main Authors: Tania Ahuja, Kelly Sessa, Cristian Merchan, John Papadopoulos, David Green
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:Advances in Hematology
Online Access:http://dx.doi.org/10.1155/2021/8870015

Similar Items

Similar Items